Hotline: +86-18022463983    020-85206863

Global Fungal Infection Diagnosis Market Size, Manufacturers, Supply Chain, Sales Channel and Clients, 2025-2031

Published Date: 2025-06-25   |   Pages: 145   |   Tables: 133   |  Medical Care

In 2024, the global market size of Fungal Infection Diagnosis was estimated to be worth US$ 117 million and is forecast to reach approximately US$ 289 million by 2031 with a CAGR of 14.0% during the forecast period 2025-2031.
Global key players of Fungal Infection Diagnosis include Era Biology, Dynamiker Biotechnology, Bio-Rad, Associates of Cape Cod, Zhanjiang A & C Biological, etc. The top five players hold a share over 61%. Asia-Pacific is the largest market, and has a share about 68%, followed by North America and Europe with share 15% and 10%, separately. In terms of product type, Galactomannan Test is the largest segment, occupied for a share of 55%. In terms of application, Hospital has a share about 80 percent.
Report Scope
This report aims to provide a comprehensive presentation of the global market for Fungal Infection Diagnosis, with both quantitative and qualitative analysis, to help readers develop business/growth strategies, assess the market competitive situation, analyze their position in the current marketplace, and make informed business decisions regarding Fungal Infection Diagnosis.
The Fungal Infection Diagnosis market size, estimations, and forecasts are provided in terms of and revenue ($ millions), considering 2024 as the base year, with history and forecast data for the period from 2020 to 2031. This report segments the global Fungal Infection Diagnosis market comprehensively. Regional market sizes, concerning products by Type, by Application, and by players, are also provided.
For a more in-depth understanding of the market, the report provides profiles of the competitive landscape, key competitors, and their respective market ranks. The report also discusses technological trends and new product developments.
The report will help the Fungal Infection Diagnosis companies, new entrants, and industry chain related companies in this market with information on the revenues for the overall market and the sub-segments across the different segments, by company, product type, application, and regions.
Market Segmentation
By Company
Associates of Cape Cod
Bio-Rad
IMMY
Era Biology
Dynamiker Biotechnology
Zhanjiang A & C Biological
Xiamen Bioendo Technology
Zhanjiang Bokang Marine Biological
Fuzhou XinBei Biochemical Industrial
Zhuhai DL Biotech
Autobio Diagnostics
Segment by Type
Galactomannan Test
(1→3)-β-D Glucan Test
Segment by Application
Hospital
Laboratory
By Region
North America
United States
Canada
Asia-Pacific
China
Japan
South Korea
India
Southeast Asia
Australia
Rest of Asia-Pacific
Europe
Germany
France
U.K.
Italy
Russia
Nordic Countries
Rest of Europe
Latin America
Mexico
Brazil
Rest of Latin America
Middle East & Africa
Turkey
Saudi Arabia
UAE
Rest of MEA
Chapter Outline
Chapter 1: Introduces the report scope of the report, executive summary of different market segments (product type, application, etc), including the market size of each market segment, future development potential, and so on.
Chapter 2: Revenue of Fungal Infection Diagnosis in global and regional level.
Chapter 3: Detailed analysis of Fungal Infection Diagnosis company competitive landscape, revenue, market share and industry ranking, latest development plan, merger, and acquisition information, etc.
Chapter 4: Provides profiles of key companies, introducing the basic situation of the main companies in the market in detail, including product descriptions and specifications, Fungal Infection Diagnosis revenue, gross margin, and recent development, etc.
Chapter 5: Provides the analysis of various market segments by Type, covering the revenue, and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 6: Provides the analysis of various market segments by Application, covering the revenue, and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 7: North America (US & Canada) by Type, by Application and by country, revenue for each segment.
Chapter 8: Europe by Type, by Application and by country, revenue for each segment.
Chapter 9: Asia Pacific by Type, by Application and by region, revenue for each segment.
Chapter 10: Latin America by Type, by Application and by country, revenue for each segment.
Chapter 11: Middle East and Africa, by Type, by Application and by country, revenue for each segment.
Chapter 12: Analysis of industrial chain, sales channel, key raw materials, distributors, and customers.
Chapter 13: Introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.
Chapter 14: Research Findings and Conclusion

Research Methodology

The research methodology employed has been subjected by numerous procedures in order to guarantee the quality and accuracy of the data contained within the reports. The analysts are employed full-time and received more than six months training to satisfy the standard of our company. Our methodology can be divided into five stages:


Stage 1 SECONDARY RESEARCH

The research team first collaborates with magazines, trade associations and administrative departments in the research field. The information provided by our internal documentation service is helpful for our further research. Our team has a wealth of experience and knowledge, and can effectively extract accurate information from existing resources.

 

Stage 2 PRIMARY RESEARCH:INTERVIEWS WITH TRADE SOURCES

After the first stage, the research team conducts a large number of face-to-face or telephone interviews with representative companies working in the research field. Analysts are trying to have an opportunity to talk to leading companies and small companies in the field. Upstream suppliers, manufacturers, distributors, importers, installers, wholesalers and consumers were included in the interview. The data collected during the interview were then carefully examined and compared with the secondary study.

 

Stage 3 ANALYSIS OF THE GATHERED DATA

The analysis team examines and synthesizes the data collected in the first two stages. In order to validate the data, a second round of interviews can be conducted.

 

Stage 4 QUANTITATIVE DATA

The quantitative data such as market estimates, production and capacity of manufacturer, market forecasts and investment feasibility is provided by our company. The data is based on the estimates obtained during stage 3.

 

Stage 5 QUALITY CONTROL

Before publishing, each report undergoes a rigorous review and editing process, which is done by the experience management team to ensure the reliability of the published data. Every analyst on the research team receives support and continuous training as part of our internal quality process.

 

1 Study Coverage
1.1 Fungal Infection Diagnosis Product Introduction
1.2 Market by Type
1.2.1 Global Fungal Infection Diagnosis Market Size Growth Rate by Type (2020 VS 2024 VS 2031)
1.2.2 Galactomannan Test
1.2.3 (1→3)-β-D Glucan Test
1.3 Market by Application
1.3.1 Global Fungal Infection Diagnosis Market Size Growth Rate by Application (2020 VS 2024 VS 2031)
1.3.2 Hospital
1.3.3 Laboratory
1.4 Assumptions and Limitations
1.5 Study Objectives
1.6 Years Considered
2 Executive Summary
2.1 Global Fungal Infection Diagnosis Market Size Estimates and Forecasts
2.2 Fungal Infection Diagnosis Market Size by Region: 2024 Versus 2031
2.2.1 Global Fungal Infection Diagnosis Revenue by Region: 2020-2025
2.2.2 Global Fungal Infection Diagnosis Revenue Forecast by Region (2026-2031)
2.2.3 Global Fungal Infection Diagnosis Revenue Market Share by Region (2020-2031)
3 Market Segments
3.1 Breakdown Data by Type
3.1.1 Global Fungal Infection Diagnosis Revenue by Type (2020-2031)
3.1.2 Global Fungal Infection Diagnosis Revenue Market Share by Type (2020-2031)
3.2 Breakdown Data by Application
3.2.1 Global Fungal Infection Diagnosis Revenue by Application (2020-2031)
3.2.2 Global Fungal Infection Diagnosis Revenue Market Share by Application (2020-2031)
3.3 by Type and by Application Crossing Analysis
3.3.1 Galactomannan Test of Fungal Infection Diagnosis Revenue Market Share by Application
3.3.2 (1→3)-β-D Glucan Test of Fungal Infection Diagnosis Revenue Market Share by Application
4 Global Fungal Infection Diagnosis by Company
4.1 Global Fungal Infection Diagnosis Revenue by Company (2020-2025)
4.2 Global Fungal Infection Diagnosis Revenue Share by Company (2020-2025)
4.3 Competitive Landscape
4.3.1 Key Fungal Infection Diagnosis Companies around the World: Ranking by Revenue
4.3.2 Global Fungal Infection Diagnosis Market Concentration Ratio (CR5 and HHI) & (2020-2025)
4.3.3 Global Fungal Infection Diagnosis Market Share by Company Type (Tier 1, Tier 2, and Tier 3)
4.4 Global Fungal Infection Diagnosis Companies Headquarters & Product Type
4.4.1 Global Fungal Infection Diagnosis Companies Headquarters
4.4.2 Date of International Companies Enter into Fungal Infection Diagnosis Market
4.4.3 Global Fungal Infection Diagnosis Companies Product & Service
4.4.4 Galactomannan Test Revenue Market Share of Fungal Infection Diagnosis by Company
4.4.5 (1→3)-β-D Glucan Test Revenue Market Share of Fungal Infection Diagnosis by Company
4.5 Global Fungal Infection Diagnosis Mergers & Acquisitions, Expansion Plans
5 Company Profiles
5.1 Associates of Cape Cod
5.1.1 Associates of Cape Cod Corporation Information
5.1.2 Associates of Cape Cod Description, Business Overview
5.1.3 Associates of Cape Cod Fungal Infection Diagnosis Products Offered
5.1.4 Associates of Cape Cod Fungal Infection Diagnosis Revenue and Gross Margin (2020-2025)
5.1.5 Associates of Cape Cod Fungal Infection Diagnosis Revenue by Product in 2024
5.1.6 Associates of Cape Cod Fungal Infection Diagnosis Revenue by Application in 2024
5.1.7 Associates of Cape Cod Fungal Infection Diagnosis Revenue by Geographic Area in 2024
5.1.8 Associates of Cape Cod Recent Developments
5.2 Bio-Rad
5.2.1 Bio-Rad Corporation Information
5.2.2 Bio-Rad Description, Business Overview
5.2.3 Bio-Rad Fungal Infection Diagnosis Products Offered
5.2.4 Bio-Rad Fungal Infection Diagnosis Revenue and Gross Margin (2020-2025)
5.2.5 Bio-Rad Fungal Infection Diagnosis Revenue by Product in 2024
5.2.6 Bio-Rad Fungal Infection Diagnosis Revenue by Application in 2024
5.2.7 Bio-Rad Fungal Infection Diagnosis Revenue by Geographic Area in 2024
5.2.8 Bio-Rad Recent Developments
5.3 IMMY
5.3.1 IMMY Corporation Information
5.3.2 IMMY Description, Business Overview
5.3.3 IMMY Fungal Infection Diagnosis Products Offered
5.3.4 IMMY Fungal Infection Diagnosis Revenue and Gross Margin (2020-2025)
5.3.5 IMMY Fungal Infection Diagnosis Revenue by Product in 2024
5.3.6 IMMY Fungal Infection Diagnosis Revenue by Application in 2024
5.3.7 IMMY Fungal Infection Diagnosis Revenue by Geographic Area in 2024
5.3.8 IMMY Recent Developments
5.4 Era Biology
5.4.1 Era Biology Corporation Information
5.4.2 Era Biology Description, Business Overview
5.4.3 Era Biology Fungal Infection Diagnosis Products Offered
5.4.4 Era Biology Fungal Infection Diagnosis Revenue and Gross Margin (2020-2025)
5.4.5 Era Biology Fungal Infection Diagnosis Revenue by Product in 2024
5.4.6 Era Biology Fungal Infection Diagnosis Revenue by Application in 2024
5.4.7 Era Biology Fungal Infection Diagnosis Revenue by Geographic Area in 2024
5.4.8 Era Biology Recent Developments
5.5 Dynamiker Biotechnology
5.5.1 Dynamiker Biotechnology Corporation Information
5.5.2 Dynamiker Biotechnology Description, Business Overview
5.5.3 Dynamiker Biotechnology Fungal Infection Diagnosis Products Offered
5.5.4 Dynamiker Biotechnology Fungal Infection Diagnosis Revenue and Gross Margin (2020-2025)
5.5.5 Dynamiker Biotechnology Fungal Infection Diagnosis Revenue by Product in 2024
5.5.6 Dynamiker Biotechnology Fungal Infection Diagnosis Revenue by Application in 2024
5.5.7 Dynamiker Biotechnology Fungal Infection Diagnosis Revenue by Geographic Area in 2024
5.5.8 Dynamiker Biotechnology Recent Developments
5.6 Zhanjiang A & C Biological
5.6.1 Zhanjiang A & C Biological Corporation Information
5.6.2 Zhanjiang A & C Biological Description, Business Overview
5.6.3 Zhanjiang A & C Biological Fungal Infection Diagnosis Products Offered
5.6.4 Zhanjiang A & C Biological Fungal Infection Diagnosis Revenue and Gross Margin (2020-2025)
5.6.5 Zhanjiang A & C Biological Fungal Infection Diagnosis Revenue by Product in 2024
5.6.6 Zhanjiang A & C Biological Fungal Infection Diagnosis Revenue by Application in 2024
5.6.7 Zhanjiang A & C Biological Fungal Infection Diagnosis Revenue by Geographic Area in 2024
5.6.8 Zhanjiang A & C Biological Recent Developments
5.7 Xiamen Bioendo Technology
5.7.1 Xiamen Bioendo Technology Corporation Information
5.7.2 Xiamen Bioendo Technology Description, Business Overview
5.7.3 Xiamen Bioendo Technology Fungal Infection Diagnosis Products Offered
5.7.4 Xiamen Bioendo Technology Fungal Infection Diagnosis Revenue and Gross Margin (2020-2025)
5.7.5 Xiamen Bioendo Technology Fungal Infection Diagnosis Revenue by Product in 2024
5.7.6 Xiamen Bioendo Technology Fungal Infection Diagnosis Revenue by Application in 2024
5.7.7 Xiamen Bioendo Technology Fungal Infection Diagnosis Revenue by Geographic Area in 2024
5.7.8 Xiamen Bioendo Technology Recent Developments
5.8 Zhanjiang Bokang Marine Biological
5.8.1 Zhanjiang Bokang Marine Biological Corporation Information
5.8.2 Zhanjiang Bokang Marine Biological Description, Business Overview
5.8.3 Zhanjiang Bokang Marine Biological Fungal Infection Diagnosis Products Offered
5.8.4 Zhanjiang Bokang Marine Biological Fungal Infection Diagnosis Revenue and Gross Margin (2020-2025)
5.8.5 Zhanjiang Bokang Marine Biological Fungal Infection Diagnosis Revenue by Product in 2024
5.8.6 Zhanjiang Bokang Marine Biological Fungal Infection Diagnosis Revenue by Application in 2024
5.8.7 Zhanjiang Bokang Marine Biological Fungal Infection Diagnosis Revenue by Geographic Area in 2024
5.8.8 Zhanjiang Bokang Marine Biological Recent Developments
5.9 Fuzhou XinBei Biochemical Industrial
5.9.1 Fuzhou XinBei Biochemical Industrial Corporation Information
5.9.2 Fuzhou XinBei Biochemical Industrial Description, Business Overview
5.9.3 Fuzhou XinBei Biochemical Industrial Fungal Infection Diagnosis Products Offered
5.9.4 Fuzhou XinBei Biochemical Industrial Fungal Infection Diagnosis Revenue and Gross Margin (2020-2025)
5.9.5 Fuzhou XinBei Biochemical Industrial Fungal Infection Diagnosis Revenue by Product in 2024
5.9.6 Fuzhou XinBei Biochemical Industrial Fungal Infection Diagnosis Revenue by Application in 2024
5.9.7 Fuzhou XinBei Biochemical Industrial Fungal Infection Diagnosis Revenue by Geographic Area in 2024
5.9.8 Fuzhou XinBei Biochemical Industrial Recent Developments
5.10 Zhuhai DL Biotech
5.10.1 Zhuhai DL Biotech Corporation Information
5.10.2 Zhuhai DL Biotech Description, Business Overview
5.10.3 Zhuhai DL Biotech Fungal Infection Diagnosis Products Offered
5.10.4 Zhuhai DL Biotech Fungal Infection Diagnosis Revenue and Gross Margin (2020-2025)
5.10.5 Zhuhai DL Biotech Fungal Infection Diagnosis Revenue by Product in 2024
5.10.6 Zhuhai DL Biotech Fungal Infection Diagnosis Revenue by Application in 2024
5.10.7 Zhuhai DL Biotech Fungal Infection Diagnosis Revenue by Geographic Area in 2024
5.10.8 Zhuhai DL Biotech Recent Developments
5.11 Autobio Diagnostics
5.11.1 Autobio Diagnostics Corporation Information
5.11.2 Autobio Diagnostics Description, Business Overview
5.11.3 Autobio Diagnostics Fungal Infection Diagnosis Products Offered
5.11.4 Autobio Diagnostics Fungal Infection Diagnosis Revenue and Gross Margin (2020-2025)
5.11.5 Autobio Diagnostics Fungal Infection Diagnosis Revenue by Product in 2024
5.11.6 Autobio Diagnostics Fungal Infection Diagnosis Revenue by Application in 2024
5.11.7 Autobio Diagnostics Fungal Infection Diagnosis Revenue by Geographic Area in 2024
5.11.8 Autobio Diagnostics Recent Developments
6 North America
6.1 North America Fungal Infection Diagnosis Market Size YoY Growth 2020-2031
6.2 North America Fungal Infection Diagnosis Market Facts & Figures by Country (2020-2031)
6.3 North America Fungal Infection Diagnosis Revenue by Type (2020-2025)
6.4 North America Fungal Infection Diagnosis Revenue by Application (2020-2025)
7 Asia-Pacific
7.1 Asia-Pacific Fungal Infection Diagnosis Market Size YoY Growth 2020-2031
7.2 Asia-Pacific Fungal Infection Diagnosis Market Facts & Figures by Region (2020-2031)
7.3 Asia-Pacific Fungal Infection Diagnosis Revenue by Type (2020-2025)
7.4 Asia-Pacific Fungal Infection Diagnosis Revenue by Application (2020-2025)
8 Europe
8.1 Europe Fungal Infection Diagnosis Market Size YoY Growth 2020-2031
8.2 Europe Fungal Infection Diagnosis Market Facts & Figures by Country (2020-2031)
8.3 Europe Fungal Infection Diagnosis Revenue by Type (2020-2025)
8.4 Europe Fungal Infection Diagnosis Revenue by Application (2020-2025)
9 Latin America
9.1 Latin America Fungal Infection Diagnosis Market Size YoY Growth 2020-2031
9.2 Latin America Fungal Infection Diagnosis Market Facts & Figures by Country (2020-2031)
9.3 Latin America Fungal Infection Diagnosis Revenue by Type (2020-2025)
9.4 Latin America Fungal Infection Diagnosis Revenue by Application (2020-2025)
10 Middle East and Africa
10.1 Latin America Fungal Infection Diagnosis Market Size YoY Growth 2020-2031
10.2 Middle East and Africa Fungal Infection Diagnosis Market Facts & Figures by Country (2020-2031)
10.3 Middle East and Africa Fungal Infection Diagnosis Revenue by Type (2020-2025)
10.4 Middle East and Africa Fungal Infection Diagnosis Revenue by Application (2020-2025)
11 Supply Chain and Sales Channel analysis
11.1 Fungal Infection Diagnosis Supply Chain Analysis
11.2 Fungal Infection Diagnosis Key Raw Materials and Upstream Suppliers
11.3 Fungal Infection Diagnosis Clients Analysis
11.4 Fungal Infection Diagnosis Sales Channel and Sales Model Analysis
11.4.1 Fungal Infection Diagnosis Distribution Channel Analysis: Indirect Sales VS Direct Sales
11.4.2 Fungal Infection Diagnosis Distribution Channel Analysis: Online Sales VS Offline Sales
11.4.3 Fungal Infection Diagnosis Distributors
12 Fungal Infection Diagnosis Market Dynamics
12.1 Fungal Infection Diagnosis Industry Trends
12.2 Fungal Infection Diagnosis Market Drivers
12.3 Fungal Infection Diagnosis Market Challenges
12.4 Fungal Infection Diagnosis Market Restraints
13 Research Findings and Conclusion
14 Appendix
14.1 Research Methodology
14.1.1 Methodology/Research Approach
14.1.1.1 Research Programs/Design
14.1.1.2 Market Size Estimation
14.1.1.3 Market Breakdown and Data Triangulation
14.1.2 Data Source
14.1.2.1 Secondary Sources
14.1.2.2 Primary Sources
14.2 Author Details
14.3 Disclaimer

List of Tables
Table 1. Global Fungal Infection Diagnosis Market Size Growth Rate (CAGR) by Type (US$ Million): 2020 VS 2024 VS 2031
Table 2. Global Fungal Infection Diagnosis Market Size Growth by Application (US$ Million): 2020 VS 2024 VS 2031
Table 3. Global Fungal Infection Diagnosis Market Size by Region (US$ Million): 2024 VS 2031
Table 4. Global Fungal Infection Diagnosis Revenue by Region (2020-2025) & (US$ Million)
Table 5. Global Fungal Infection Diagnosis Revenue Forecast by Region (2026-2031) & (US$ Million)
Table 6. Global Fungal Infection Diagnosis Revenue by Type (2020-2025) & (US$ Million)
Table 7. Global Fungal Infection Diagnosis Revenue Forecast by Type (2026-2031) & (US$ Million)
Table 8. Global Fungal Infection Diagnosis Revenue by Application (2020-2025) & (US$ Million)
Table 9. Global Fungal Infection Diagnosis Revenue Forecast by Application (2026-2031) & (US$ Million)
Table 10. Fungal Infection Diagnosis Revenue by Company (2020-2025) & (US$ Million)
Table 11. Fungal Infection Diagnosis Revenue Share by Company (2020-2025)
Table 12. Ranking of Global Top Fungal Infection Diagnosis Players by Revenue (US$ Million) in 2024
Table 13. Global Fungal Infection Diagnosis Companies Market Concentration Ratio (CR5 and HHI) & (2020-2025)
Table 14. Global Fungal Infection Diagnosis by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Fungal Infection Diagnosis as of 2024)
Table 15. Global Fungal Infection Diagnosis Companies Headquarters
Table 16. Date of International Companies Enter into Fungal Infection Diagnosis Market
Table 17. Global Fungal Infection Diagnosis Companies Product & Service
Table 18. Global Fungal Infection Diagnosis Mergers & Acquisitions, Expansion Plans
Table 19. Associates of Cape Cod Corporation Information
Table 20. Associates of Cape Cod Description and Business Overview
Table 21. Associates of Cape Cod Fungal Infection Diagnosis Product
Table 22. Associates of Cape Cod Fungal Infection Diagnosis Revenue (US$ Million) and Gross Margin (2020-2025)
Table 23. Associates of Cape Cod Revenue Proportion of Fungal Infection Diagnosis by Product in 2024
Table 24. Associates of Cape Cod Revenue Proportion of Fungal Infection Diagnosis by Application in 2024
Table 25. Associates of Cape Cod Revenue Proportion of Fungal Infection Diagnosis by Geographic Area in 2024
Table 26. Associates of Cape Cod Recent Developments
Table 27. Bio-Rad Corporation Information
Table 28. Bio-Rad Description and Business Overview
Table 29. Bio-Rad Fungal Infection Diagnosis Product
Table 30. Bio-Rad Fungal Infection Diagnosis Revenue (US$ Million) and Gross Margin (2020-2025)
Table 31. Bio-Rad Revenue Proportion of Fungal Infection Diagnosis by Product in 2024
Table 32. Bio-Rad Revenue Proportion of Fungal Infection Diagnosis by Application in 2024
Table 33. Bio-Rad Revenue Proportion of Fungal Infection Diagnosis by Geographic Area in 2024
Table 34. Bio-Rad Recent Developments
Table 35. IMMY Corporation Information
Table 36. IMMY Description and Business Overview
Table 37. IMMY Fungal Infection Diagnosis Product
Table 38. IMMY Fungal Infection Diagnosis Revenue (US$ Million) and Gross Margin (2020-2025)
Table 39. IMMY Revenue Proportion of Fungal Infection Diagnosis by Product in 2024
Table 40. IMMY Revenue Proportion of Fungal Infection Diagnosis by Application in 2024
Table 41. IMMY Revenue Proportion of Fungal Infection Diagnosis by Geographic Area in 2024
Table 42. IMMY Recent Developments
Table 43. Era Biology Corporation Information
Table 44. Era Biology Description and Business Overview
Table 45. Era Biology Fungal Infection Diagnosis Product
Table 46. Era Biology Fungal Infection Diagnosis Revenue (US$ Million) and Gross Margin (2020-2025)
Table 47. Era Biology Revenue Proportion of Fungal Infection Diagnosis by Product in 2024
Table 48. Era Biology Revenue Proportion of Fungal Infection Diagnosis by Application in 2024
Table 49. Era Biology Revenue Proportion of Fungal Infection Diagnosis by Geographic Area in 2024
Table 50. Era Biology Recent Developments
Table 51. Dynamiker Biotechnology Corporation Information
Table 52. Dynamiker Biotechnology Description and Business Overview
Table 53. Dynamiker Biotechnology Fungal Infection Diagnosis Product
Table 54. Dynamiker Biotechnology Fungal Infection Diagnosis Revenue (US$ Million) and Gross Margin (2020-2025)
Table 55. Dynamiker Biotechnology Revenue Proportion of Fungal Infection Diagnosis by Product in 2024
Table 56. Dynamiker Biotechnology Revenue Proportion of Fungal Infection Diagnosis by Application in 2024
Table 57. Dynamiker Biotechnology Revenue Proportion of Fungal Infection Diagnosis by Geographic Area in 2024
Table 58. Dynamiker Biotechnology Recent Developments
Table 59. Zhanjiang A & C Biological Corporation Information
Table 60. Zhanjiang A & C Biological Description and Business Overview
Table 61. Zhanjiang A & C Biological Fungal Infection Diagnosis Product
Table 62. Zhanjiang A & C Biological Fungal Infection Diagnosis Revenue (US$ Million) and Gross Margin (2020-2025)
Table 63. Zhanjiang A & C Biological Revenue Proportion of Fungal Infection Diagnosis by Product in 2024
Table 64. Zhanjiang A & C Biological Revenue Proportion of Fungal Infection Diagnosis by Application in 2024
Table 65. Zhanjiang A & C Biological Revenue Proportion of Fungal Infection Diagnosis by Geographic Area in 2024
Table 66. Zhanjiang A & C Biological Recent Developments
Table 67. Xiamen Bioendo Technology Corporation Information
Table 68. Xiamen Bioendo Technology Description and Business Overview
Table 69. Xiamen Bioendo Technology Fungal Infection Diagnosis Product
Table 70. Xiamen Bioendo Technology Fungal Infection Diagnosis Revenue (US$ Million) and Gross Margin (2020-2025)
Table 71. Xiamen Bioendo Technology Revenue Proportion of Fungal Infection Diagnosis by Product in 2024
Table 72. Xiamen Bioendo Technology Revenue Proportion of Fungal Infection Diagnosis by Application in 2024
Table 73. Xiamen Bioendo Technology Revenue Proportion of Fungal Infection Diagnosis by Geographic Area in 2024
Table 74. Xiamen Bioendo Technology Recent Developments
Table 75. Zhanjiang Bokang Marine Biological Corporation Information
Table 76. Zhanjiang Bokang Marine Biological Description and Business Overview
Table 77. Zhanjiang Bokang Marine Biological Fungal Infection Diagnosis Product
Table 78. Zhanjiang Bokang Marine Biological Fungal Infection Diagnosis Revenue (US$ Million) and Gross Margin (2020-2025)
Table 79. Zhanjiang Bokang Marine Biological Revenue Proportion of Fungal Infection Diagnosis by Product in 2024
Table 80. Zhanjiang Bokang Marine Biological Revenue Proportion of Fungal Infection Diagnosis by Application in 2024
Table 81. Zhanjiang Bokang Marine Biological Revenue Proportion of Fungal Infection Diagnosis by Geographic Area in 2024
Table 82. Zhanjiang Bokang Marine Biological Recent Developments
Table 83. Fuzhou XinBei Biochemical Industrial Corporation Information
Table 84. Fuzhou XinBei Biochemical Industrial Description and Business Overview
Table 85. Fuzhou XinBei Biochemical Industrial Fungal Infection Diagnosis Product
Table 86. Fuzhou XinBei Biochemical Industrial Fungal Infection Diagnosis Revenue (US$ Million) and Gross Margin (2020-2025)
Table 87. Fuzhou XinBei Biochemical Industrial Revenue Proportion of Fungal Infection Diagnosis by Product in 2024
Table 88. Fuzhou XinBei Biochemical Industrial Revenue Proportion of Fungal Infection Diagnosis by Application in 2024
Table 89. Fuzhou XinBei Biochemical Industrial Revenue Proportion of Fungal Infection Diagnosis by Geographic Area in 2024
Table 90. Fuzhou XinBei Biochemical Industrial Recent Developments
Table 91. Zhuhai DL Biotech Corporation Information
Table 92. Zhuhai DL Biotech Description and Business Overview
Table 93. Zhuhai DL Biotech Fungal Infection Diagnosis Product
Table 94. Zhuhai DL Biotech Fungal Infection Diagnosis Revenue (US$ Million) and Gross Margin (2020-2025)
Table 95. Zhuhai DL Biotech Revenue Proportion of Fungal Infection Diagnosis by Product in 2024
Table 96. Zhuhai DL Biotech Revenue Proportion of Fungal Infection Diagnosis by Application in 2024
Table 97. Zhuhai DL Biotech Revenue Proportion of Fungal Infection Diagnosis by Geographic Area in 2024
Table 98. Zhuhai DL Biotech Recent Developments
Table 99. Autobio Diagnostics Corporation Information
Table 100. Autobio Diagnostics Description and Business Overview
Table 101. Autobio Diagnostics Fungal Infection Diagnosis Product
Table 102. Autobio Diagnostics Fungal Infection Diagnosis Revenue (US$ Million) and Gross Margin (2020-2025)
Table 103. Autobio Diagnostics Revenue Proportion of Fungal Infection Diagnosis by Product in 2024
Table 104. Autobio Diagnostics Revenue Proportion of Fungal Infection Diagnosis by Application in 2024
Table 105. Autobio Diagnostics Revenue Proportion of Fungal Infection Diagnosis by Geographic Area in 2024
Table 106. Autobio Diagnostics Recent Developments
Table 107. North America Fungal Infection Diagnosis Revenue by Country (2020-2025) & (US$ Million)
Table 108. North America Fungal Infection Diagnosis Revenue by Country (2026-2031) & (US$ Million)
Table 109. North America Fungal Infection Diagnosis Revenue by Type (2020-2025) & (US$ Million)
Table 110. North America Fungal Infection Diagnosis Revenue by Application (2020-2025) & (US$ Million)
Table 111. Asia-Pacific Fungal Infection Diagnosis Revenue by Region (2020-2025) & (US$ Million)
Table 112. Asia-Pacific Fungal Infection Diagnosis Revenue by Region (2026-2031) & (US$ Million)
Table 113. Asia-Pacific Fungal Infection Diagnosis Revenue by Type (2020-2025) & (US$ Million)
Table 114. Asia-Pacific Fungal Infection Diagnosis Revenue by Application (2020-2025) & (US$ Million)
Table 115. Europe Fungal Infection Diagnosis Revenue by Country (2020-2025) & (US$ Million)
Table 116. Europe Fungal Infection Diagnosis Revenue by Country (2026-2031) & (US$ Million)
Table 117. Europe Fungal Infection Diagnosis Revenue by Type (2020-2025) & (US$ Million)
Table 118. Europe Fungal Infection Diagnosis Revenue by Application (2020-2025) & (US$ Million)
Table 119. Latin America Fungal Infection Diagnosis Revenue by Country (2020-2025) & (US$ Million)
Table 120. Latin America Fungal Infection Diagnosis Revenue by Country (2026-2031) & (US$ Million)
Table 121. Latin America Fungal Infection Diagnosis Revenue by Type (2020-2025) & (US$ Million)
Table 122. Latin America Fungal Infection Diagnosis Revenue by Application (2020-2025) & (US$ Million)
Table 123. Middle East and Africa Fungal Infection Diagnosis Revenue by Country (2020-2025) & (US$ Million)
Table 124. Middle East and Africa Fungal Infection Diagnosis Revenue by Country (2026-2031) & (US$ Million)
Table 125. Middle East and Africa Fungal Infection Diagnosis Revenue by Type (2020-2025) & (US$ Million)
Table 126. Middle East and Africa Fungal Infection Diagnosis Revenue by Application (2020-2025) & (US$ Million)
Table 127. Fungal Infection Diagnosis Key Raw Materials, Industry Status and Trend
Table 128. Fungal Infection Diagnosis Key Raw Materials and Upstream Suppliers
Table 129. Fungal Infection Diagnosis Clients Status and Trend
Table 130. Fungal Infection Diagnosis Typical Clients
Table 131. Fungal Infection Diagnosis Distributors
Table 132. Fungal Infection Diagnosis Market Trends
Table 133. Fungal Infection Diagnosis Market Drivers
Table 134. Fungal Infection Diagnosis Market Challenges
Table 135. Fungal Infection Diagnosis Market Restraints
Table 136. Research Programs/Design for This Report
Table 137. Key Data Information from Secondary Sources
Table 138. Key Data Information from Primary Sources


List of Figures
Figure 1. Fungal Infection Diagnosis Product Picture
Figure 2. Global Fungal Infection Diagnosis Market Size by Type (US$ Million): 2020 VS 2024 VS 2031
Figure 3. Global Fungal Infection Diagnosis Revenue Market Share by Type in 2024 & 2031
Figure 4. Galactomannan Test Product Picture
Figure 5. (1→3)-β-D Glucan Test Product Picture
Figure 6. Global Fungal Infection Diagnosis Market Size by Application (US$ Million): 2020 VS 2024 VS 2031
Figure 7. Global Fungal Infection Diagnosis Revenue Market Share by Application in 2024 & 2031
Figure 8. Hospital
Figure 9. Laboratory
Figure 10. Fungal Infection Diagnosis Report Years Considered
Figure 11. Global Fungal Infection Diagnosis Revenue, (US$ Million), 2020 VS 2024 VS 2031
Figure 12. Global Fungal Infection Diagnosis Market Size (2020-2031) & (US$ Million)
Figure 13. Global Fungal Infection Diagnosis Market Size Market Share by Region: 2024 Versus 2031
Figure 14. Global Fungal Infection Diagnosis Revenue Market Share by Region (2020-2031)
Figure 15. Global Fungal Infection Diagnosis Revenue Market Share Forecast by Type (2020-2031)
Figure 16. Global Fungal Infection Diagnosis Revenue Market Share Forecast by Application (2020-2031)
Figure 17. Galactomannan Test of Fungal Infection Diagnosis Revenue Market Share by Application, 2024 VS 2031
Figure 18. (1→3)-β-D Glucan Test of Fungal Infection Diagnosis Revenue Market Share by Application, 2024 VS 2031
Figure 19. Fungal Infection Diagnosis Revenue Share by Company (2024)
Figure 20. Fungal Infection Diagnosis Market Share by Company Type (Tier 1, Tier 2, and Tier 3): 2020 VS 2024
Figure 21. Galactomannan Test Revenue Proportion by Company in 2024
Figure 22. (1→3)-β-D Glucan Test Revenue Proportion by Company in 2024
Figure 23. North America Fungal Infection Diagnosis Revenue 2020-2031 (US$ Million)
Figure 24. North America Fungal Infection Diagnosis Revenue Market Share by Type (2020-2025)
Figure 25. North America Fungal Infection Diagnosis Revenue Market Share by Application (2020-2025)
Figure 26. Asia-Pacific Fungal Infection Diagnosis Revenue 2020-2031 (US$ Million)
Figure 27. Asia-Pacific Fungal Infection Diagnosis Revenue Market Share by Region (2020-2031)
Figure 28. Asia-Pacific Fungal Infection Diagnosis Revenue Market Share by Type (2020-2025)
Figure 29. Asia-Pacific Fungal Infection Diagnosis Revenue Market Share by Application (2020-2025)
Figure 30. Europe Fungal Infection Diagnosis Revenue Growth Rate 2020-2031 (US$ Million)
Figure 31. Europe Fungal Infection Diagnosis Revenue Market Share by Country (2020-2031)
Figure 32. Europe Fungal Infection Diagnosis Revenue Market Share by Type (2020-2025)
Figure 33. Europe Fungal Infection Diagnosis Revenue Market Share by Application (2020-2025)
Figure 34. Latin America Fungal Infection Diagnosis Revenue Growth Rate 2020-2031 (US$ Million)
Figure 35. Latin America Fungal Infection Diagnosis Revenue Market Share by Country (2020-2031)
Figure 36. Latin America Fungal Infection Diagnosis Revenue Market Share by Type (2020-2025)
Figure 37. Latin America Fungal Infection Diagnosis Revenue Market Share by Application (2020-2025)
Figure 38. Middle East and Africa Fungal Infection Diagnosis Revenue Growth Rate 2020-2031 (US$ Million)
Figure 39. Middle East and Africa Fungal Infection Diagnosis Revenue Market Share by Country (2020-2031)
Figure 40. Middle East and Africa Fungal Infection Diagnosis Revenue Market Share by Type (2020-2025)
Figure 41. Middle East and Africa Fungal Infection Diagnosis Revenue Market Share by Application (2020-2025)
Figure 42. Fungal Infection Diagnosis Supply Chain (Upstream and Downstream Market)
Figure 43. Global Production Market Share of Fungal Infection Diagnosis Raw Materials by Region in 2024
Figure 44. Fungal Infection Diagnosis Distribution Channels
Figure 45. Global Fungal Infection Diagnosis Percentage 2020-2031: Indirect Sales VS Direct Sales
Figure 46. Global Fungal Infection Diagnosis Percentage 2020-2031: Online Sales VS Offline Sales
Figure 47. Bottom-up and Top-down Approaches for This Report
Figure 48. Data Triangulation
Figure 49. Key Executives Interviewed

Our Clients